Actionnariat et activité des initiés pour PharmaCyte Biotech, Inc. (PMCB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.42 |
| Capitalisation | $4M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-03-31 | WALKER WAYNE REMELL | J-Other | ||
| 2026-03-31 | Abecassis Michael M | J-Other | ||
| 2026-03-31 | SCHECHTER JONATHAN | J-Other | ||
| 2026-03-31 | WEINSTEIN ROBERT | J-Other | ||
| 2026-03-31 | WEINSTEIN ROBERT | A-Award | 119,170 | $80K |
| 2026-03-31 | WALKER WAYNE REMELL | A-Award | 119,170 | $80K |
| 2026-03-31 | SCHECHTER JONATHAN | A-Award | 119,170 | $80K |
| 2026-03-31 | Abecassis Michael M | A-Award | 119,170 | $80K |
| 2026-01-07 | Silverman Joshua | P-Purchase | 40,000 | $33K |
| 2026-01-06 | Silverman Joshua | P-Purchase | 30,000 | $24K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $3.5M | $1.1M | $515253 | $894861 | $2.2M | $85.4M | $68.0M | $50.2M | $15.2M | $18.6M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $366316 | $18.5M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.7M | $240766 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $3.5M | $1.3M | $653404 | $1.0M | $2.3M | $85.5M | $68.1M | $50.4M | $22.4M | $37.4M |
| Immobilisations Corporelles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $1.5M | $1.5M | 0 |
| Actifs Totaux | $8.7M | $6.4M | $5.8M | $6.2M | $7.4M | $90.6M | $73.3M | $59.9M | $55.2M | $46.8M |
| Dettes Fournisseurs | $365600 | $352621 | $121885 | $185842 | $172261 | $205361 | $128281 | $389369 | $399204 | $271102 |
| Dette à Court Terme | 0 | 0 | 0 | $28918 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $580248 | $644168 | $742851 | $1.0M | $724778 | $704370 | $586581 | $7.4M | $2.9M | $826424 |
| Dette à Long Terme | 0 | 0 | 0 | $46282 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $580248 | $644168 | $742851 | $1.1M | $724778 | $704370 | $586581 | $20.4M | $3.3M | $11.8M |
| Réserves | -$89.1M | -$96.0M | -$100.0M | -$103.9M | -$107.4M | -$111.6M | -$116.0M | -$115.6M | -$85.0M | -$104.4M |
| Capitaux Propres | $8.1M | $5.8M | $5.0M | $5.1M | $6.7M | $89.9M | $72.7M | $39.5M | $51.9M | $33.3M |
| Dette Totale | 0 | 0 | 0 | $75200 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dette Nette | -$3.5M | -$1.1M | -$515253 | -$819661 | -$2.2M | -$85.4M | -$68.0M | -$50.2M | -$15.5M | -$37.1M |
| Fonds de Roulement | $3.0M | $639697 | -$89447 | $6248 | $1.6M | $84.8M | $67.6M | $43.0M | $19.5M | $36.6M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 45.28 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -2.67 |
Rentabilité
| Rentabilité des capitaux propres | -50.84% |
| Rentabilité du capital investi | -14.92% |
| Rentabilité des actifs | -41.55% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: BCLI · CYCN · IBO · KTTA · NBY · PLRZ · QNRX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de PMCB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions